BioCentury
ARTICLE | Distillery Therapeutics

An engineered ACE2 fusion protein as a COVID-19 therapy

July 2, 2021 12:34 AM GMT
Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article